LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Feb 7, 2019
Clinical News
Aminex shows MYCN is a regulator of the polyamine pathway
Read More
BioCentury
|
Feb 1, 2019
Preclinical News
Aminex shows MYCN is a regulator of the polyamine pathway
Read More
BioCentury
|
Jan 29, 2019
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Nov 29, 2018
Translation in Brief
Beyond BRCA
Markers beyond BRCA to identify patients who could benefit from PARP inhibitors
Read More
BioCentury
|
Nov 2, 2018
Targets & Mechanisms
FDA’s pediatric target picks
FDA looks beyond company pipeline horizons for pediatric oncology targets
Read More
BioCentury
|
Apr 10, 2018
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Mar 13, 2018
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Feb 6, 2018
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Oct 17, 2017
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Sep 21, 2017
Translation in Brief
Driving CARs into neuroblastoma
How new neuroblastoma targets could lead to CAR T cells for high-risk disease
Read More
Items per page:
10
1 - 10 of 26